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2433We assume that increased NRR is an early sign of impending
heart failure prompted by either subclinical pulmonary congestion
or by altered autonomic control of respiratory activity (1). We
foresee potential roles of NRR for future risk stratiﬁcation ap-
proaches. Currently, LVEF is the mainstay of post-MI risk
assessment, as the decision whether to implant a deﬁbrillator is
based mainly on LVEF. NRR might prove helpful by identi-
fying patients who are less likely to beneﬁt from ICD implantation
because of a high N-SCD prevalence. Among patients with
LVEF 35% (i.e., ICD candidates), increased NRR identiﬁes a
group of patients with frequent N-SCD (i.e., a mode of death likely
not implantable cardioverter-deﬁbrillator [ICD] preventable).
Moreover, it cannot be excluded that ICD implantation might be
harmful in some of these patients.
Independent validation of this new risk stratiﬁcation approach
is necessary before it can be incorporated into clinical decision
making. Most importantly, the post-hoc assigned cause-speciﬁc
mortalities can only provide an approximation of deaths that may
and may not be prevented by ICD implantation. While a deﬁnite
proof of the hypothesis would require a prospective study per-
formed in ICD candidates, the methodology presented here also
allows for independent conﬁrmatory analyses in datasets from ICD
primary prevention studies, provided that digitized Holter re-
cordings are available.Michael Dommasch, MDy
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2013;34:1644–50.Letters to the EditorBaroreﬂex Sensitivity
and Renal Sympathetic
Denervation
We read with great interest the study by Zuern et al. (1) about the
possibility of predicting for the ﬁrst time the response to renal
sympathetic denervation (RDN) in patients with resistant hyper-
tension, using cardiac baroreﬂex sensitivity (BRS).
This fascinating report demonstrates that 1) the antihypertensive
effect of RDN was greater in patients with impaired BRS, and
2) this effect was associated with restoration of BRS after the
procedure. These positive results were obtained with BRS measured
in 2 ways, namely, the classical sequence method (BRSseq) and the
bivariate phase rectiﬁed signal averaging method (BRSprsa). In this
study of 50 patients, analysis of receiver operating characteristic
(ROC) curves showed that BRSprsa was a better predictor of the
hypotensive effect of RDN than BRSseq. Consequently, the in-
vestigators focused the rest of the analysis on BRSprsa using a
more complex and accurate predictive model. It would, neverthe-
less, be a pity at this stage of RDN development to ignore BRSseq,
which is the only BRS measurement technique that beneﬁts from
prognostic data in patients with hypertension. The EVABAR
(Evaluation of the Prognostic Value of Baroreﬂex Sensitivity in
Hypertensive Patients) study, which investigated a cohort of 451
patients with hypertension with no particular history who were
followed for an average of 6.2 years, demonstrated the prognostic
role of BRSseq for cardiovascular events (2). Using a BRS mea-
surement technique that beneﬁts from prognostic data is all the
more relevant because there does not currently exist any method of
identifying those patients with hypertension whose prognosis
might be improved by RDN (above and beyond lower blood
pressure).
In addition, the accompanying editorial (2) emphasized the
fact that BRS was not uniformly predictive for all patients with
hypertension nor did it predict the magnitude of blood pressure
reduction. The results of Zuern et al. (1) would suggest that
the value of higher-resolution analysis of BRS was to determine
whether the sympathetic component on its own or the sympathetic/
parasympathetic balance would improve prediction of the efﬁcacy
of RDN on blood pressure. Distinguishing between BRSseq “up”
and “down” sequences would make it easier to weigh the sympa-
thetic and parasympathetic contributions (3,4).*Olivier Ormezzano, MD, PhD
Jean-Philippe Baguet, MD, PhD
*Clinic of Cardiology
Joseph Fourier University
University Hospital of Grenoble
38043 Grenoble
France
E-mail: oormezzano@chu-grenoble.fr
http://dx.doi.org/10.1016/j.jacc.2013.12.048
Correspondence JACC Vol. 63, No. 22, 2014
June 10, 2014:2432–7
2434REFERENCES
1. Zuern CS, Eick C, Rizas KD, et al. Impaired cardiac baroreﬂex
sensitivity predicts response to renal sympathetic denervation in
patients with resistant hypertension. J Am Coll Cardiol 2013;62:
2124–30.
2. Kandzari DE, Sobotka PA. Ready for a marathon, not a sprint: renal
denervation therapy for treatment-resistant hypertension. J Am Coll
Cardiol 2013;62:2131–3.
3. Ormezzano O, Cracowski JL, Quesada JL, Pierre H, Mallion JM,
Baguet JP. Evaluation of the prognostic value of baroreﬂex sensitivity
in hypertensive patients: the EVABAR study. J Hypertens 2008;26:
1373–8.
4. Martin-Vazquez M, Reyes Del Paso GA. Physical training and the
dynamics of the cardiac baroreﬂex: a comparison when blood pressure
rises and falls. Int J Psychophysiol 2010;76:142–7.ReplyBaroreﬂex Sensitivity and
Renal Sympathetic DenervationWe appreciate the insightful comments of Drs. Ormezzano
and Baguet on our paper (1). In our proof-of-concept study,
we demonstrated for the ﬁrst time that impaired spontaneous
cardiac baroreﬂex sensitivity (BRS) might be a valuable tool for
identiﬁcation of patients with hypertension who might beneﬁt
from renal sympathetic denervation (RDN). It is correct that
we assessed BRS in 2 ways, namely, by phase-rectiﬁed signal
averaging (PRSA; BRSPRSA) and by the sequence method
(BRSSEQ). It is also correct that the prognostic value of
BRSPRSA in predicting response to RDN was superior to that
of BRSSEQ. However, our study was neither powered nor
intended to compare the predictive values of different BRS
measures. According to our pre-speciﬁed hypothesis, we deﬁned
BRSPRSA as the primary variable, which was therefore tested in
multivariate models. Importantly, we did not show that RDN led
to restoration of impaired BRS as mentioned by Drs. Ormezzano
and Baguet. This interesting hypothesis will be tested in up-
coming projects.
The assessment of BRS by PRSA is conceptually new and
differs from previous approaches to BRS assessment in many
aspects. PRSA is a comprehensive signal processing technology
that is capable of extracting periodic patterns out of complex
biological signals such as recordings of heart rate, blood pressure,
and respiratory activity (2,3). An extension of the PRSA tech-
nology allows the analysis of coupled periodic patterns in simul-
taneously recorded biosignals, which is of obvious advantage in
assessment of spontaneous BRS (4,5). We agree that the prog-
nostic value of a BRS measure is of great importance. The
prognostic value of BRSPRSA has been prospectively validated in
941 surviving patients with acute myocardial infarction, for which
it proved to be superior to that of BRSSEQ and other techniques in
prediction of 5-year all-cause mortality (6). We acknowledge the
promising results of BRSSEQ as a risk predictor in patients with
hypertension in the EVABAR (Evaluation of the Prognostic
Value of Baroreﬂex Sensitivity in Hypertensive Patients) study.
Therefore, we would like to suggest that Drs. Ormezzano and
Baguet conduct a blinded analysis of BRSPRSA in patients of the
EVABAR study.Christine S. Zuern, MD
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Magnetic Resonance
Imaging in the Assessment
of Left Atrial Function
We read with great interest the review article by Hoit (1), in which
most of the available articles about the role of left atrial (LA)
function and size in different cardiovascular diseases have been
reviewed. As mentioned, analyzing LA function has always been
challenging, given the distance of the LA from the chest wall and
its thin asymmetrical wall. The presence of pulmonary veins and
left atrial appendage also makes it more challenging to evaluate LA
function than left ventricular function. On the other hand, cardiac
magnetic resonance imaging (CMRI) has been proposed as the
gold standard method for the assessment of LA volume. However,
as the author mentioned, inability to measure phasic volumes had
been a major limitation of CMRI.
Feature tracking (or tissue tracking) CMRI is a new technique
in the assessment of myocardial wall motion and measurement
of heart chamber volumes. This is a novel post-processing
